0
From the Centers for Disease Control and Prevention |

Recommended Childhood Immunization Schedule—United States, 2002 FREE

JAMA. 2002;287(6):707-708. doi:10.1001/jama.287.6.707.
Text Size: A A A
Published online

MMWR. 2002;51:31-33

Each year, CDC's Advisory Committee on Immunization Practices (ACIP) reviews the recommended childhood immunization schedule to ensure that it is current with changes in manufacturers' vaccine formulations, has revised recommendations for the use of licensed vaccines, and has recommendations for newly licensed vaccines. This report presents the recommended childhood immunization schedule for 2002, which has remained the same in content since January 20011 but has a redesigned format (Figure 1).

Place holder to copy figure label and caption
FIGURE 1.

Recommended childhood immunization schedule*—United States, 2002

Graphic Jump Location

The format of the 2002 schedule is based on a design developed by the Minnesota Department of Health immunization program; the recommendations and format have been approved by ACIP, the American Academy of Family Physicians, and the American Academy of Pediatrics. The new design highlights the importance of catch-up vaccination, the preadolescent visit, the preference for administering the first dose of the hepatitis B vaccine series at birth, and three vaccines for selected at-risk groups. The importance of assessing whether children aged 24 months–18 years require any catch-up vaccination is emphasized by the use of hatched bars. The schedule also underscores the visit at age 11-12 years when immunization status should be reviewed and all necessary vaccines administered.

HEPATITIS B VACCINE

The schedule indicates a preference for administering the first dose of hepatitis B vaccine to all newborns soon after birth and before hospital discharge. Administering the first dose of hepatitis B vaccine soon after birth should minimize the risk for infection because of errors in maternal hepatitis B surface antigen (HBsAg) testing or reporting, or from exposure to persons with chronic hepatitis B virus (HBV) infection in the household, and can increase the likelihood of completing the vaccine series. Only monovalent hepatitis B vaccine can be used for the birth dose. Either monovalent or combination vaccine can be used to complete the series. Four doses of hepatitis B vaccine, including the birth dose, may be administered if a combination vaccine is used to complete the series. In addition to receiving hepatitis B immune globulin (HBIG) and the hepatitis B vaccine series, infants born to HBsAg-positive mothers should be tested for HBsAg and antibody to HBsAg (anti-HBs) at age 9-15 months to identify those with chronic HBV infection or those who may require revaccination.2

VACCINES FOR SELECTED POPULATIONS

The area below the dashed line (Figure 1) displays certain vaccines recommended for use in selected populations. High-risk children aged 24-59 months should receive catch-up pneumococcal conjugate vaccine (PCV) doses, if indicated.3 Pneumococcal polysaccharide vaccine (PPV) is recommended in addition to PCV for certain high-risk groups.3 The recommendation to administer annual influenza vaccine to high-risk children also appears on the schedule.4

VACCINE SUPPLY

As a result of the vaccine supply shortage, deferral of some doses of tetanus and diphtheria toxoids (Td), diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP), and pneumococcal conjugate vaccine (PCV) has been recommended57; health-care providers should record patients for whom vaccination has been deferred and should contact them once the supply has been restored.

VACCINE INFORMATION STATEMENTS

The National Childhood Vaccine Injury Act requires that all health-care providers give parents or patients copies of Vaccine Information Statements before administering each dose of the vaccines listed in the schedule. Additional information about Vaccine Information Statements is available from state health departments and at http://www.cdc.gov/nip/publications/VIS. Detailed recommendations for using vaccines are available from the manufacturers' package inserts, ACIP statements on specific vaccines, and the 2000 Red Book.24,8 ACIP statements for each recommended childhood vaccine can be viewed, downloaded, and printed from the CDC National Immunization Program at http://www.cdc.gov/nip/publications/ACIP-list.htm; instructions on the use of the Vaccine Information Statements are available at http://www.cdc.gov/nip/publications/VIS/vis-Instructions.pdf.

REFERENCES

CDC, Recommended childhood immunization schedule—United States, 2001. MMWR. 2001;507- 10
CDC, Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1991;40 ((No. RR-13))
CDC, Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2000;49 ((No. RR-9))
CDC, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2001;50 ((No. RR-4))
CDC, Deferral of routine booster doses of tetanus and diphtheria toxoids for adolescents and adults. MMWR. 2001;50418- 27
CDC, Update: supply of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR. 2002;501159
CDC, Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage—Advisory Committee on Immunization Practices. MMWR. 2001;501140- 2
American Academy of Pediatrics, Active and passive immunization. Pickering  LKed.2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, Illinois American Academy of Pediatrics2000;1- 81

Figures

Place holder to copy figure label and caption
FIGURE 1.

Recommended childhood immunization schedule*—United States, 2002

Graphic Jump Location

Tables

References

CDC, Recommended childhood immunization schedule—United States, 2001. MMWR. 2001;507- 10
CDC, Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1991;40 ((No. RR-13))
CDC, Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2000;49 ((No. RR-9))
CDC, Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2001;50 ((No. RR-4))
CDC, Deferral of routine booster doses of tetanus and diphtheria toxoids for adolescents and adults. MMWR. 2001;50418- 27
CDC, Update: supply of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR. 2002;501159
CDC, Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage—Advisory Committee on Immunization Practices. MMWR. 2001;501140- 2
American Academy of Pediatrics, Active and passive immunization. Pickering  LKed.2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, Illinois American Academy of Pediatrics2000;1- 81
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles